Kementec Solutions A/S: Financial statements 2013
CVR: 25806735
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
Kementec Solutions A/S (CVR 25806735) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 11,469,739 and a net result of DKK 2,384,646 compared with DKK 1,106,625 the year before. That is an increase of 10.4% compared with the year before. Equity in the 2013 report amounted to DKK 4,916,459. The solvency ratio was 43.7%.
- Gross Profit
- DKK 11,469,739
- Profit/Loss
- DKK 2,384,646
- Equity
- DKK 4,916,459
- Total Assets
- DKK 11,259,582
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 11.5 mio. | 2.4 mio. | 4.9 mio. | - |
| 2012 | - | 10.4 mio. | 1.1 mio. | 3.6 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of October 1, 2013, AIDER Godkendt Revisionsaktieselskab has been appointed auditor of Kementec Solutions A/S.
As of October 1, 2013, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of Kementec Solutions A/S.
Kementec Solutions A/S has published its annual report for 2012. Gross profit came to DKK 10,385,561, and the net result was DKK 1,106,625.
About Kementec Solutions A/S
Kementec Solutions A/S is a Danish company of the type Aktieselskab based in Taastrup, founded in 2000. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named KEM-EN-TEC DIAGNOSTICS A/S. The management consists of Elaine Antonette Lundberg and Tobias Greve-Vilby. The board consists of Frank Vitzthum (chair), Christian Moraeno Dreher and Ute Salzbrenner. The company is owned by R-Biopharm AG. The company has 20 employees (2026). In 2025, the company reported a gross profit of DKK 18,706,173 and a net result of DKK 2,269,339 compared with DKK 1,565,137 the year before. Equity in the 2025 report amounted to DKK 25,366,459.